Skip to main content

Clinical Trials Using RET Inhibitor LOXO-292

Review the clinical trials studying ret inhibitor loxo-292 on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-3 of 3

Selpercatinib Prior to Radioiodine Therapy for the Treatment of Children, Adolescents, and Young Adults with Metastatic Differentiated Thyroid Cancers that Harbor a RET Fusion, RAISE Trial
Status: Active
Location: Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer
Status: Temporarily Closed to Accrual
Location: 4 locations
Biomarker-Driven Therapy and Immunotherapy in Screening Participants with Recurrent or Stage IV Non-Small Cell Lung Cancer (The Expanded Lung-MAP Screening Trial)
Status: Active
Location: 1113 locations